MPWT
ELVN icon

MassMutual Private Wealth & Trust’s Enliven Therapeutics ELVN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Hold
208
– – ﹤0.01% 1388
2026
Q1 		$8.15K Buy
208
+108
+108% +$2.99K ﹤0.01% 1446
2025
Q4 		$1.54K Buy
100
+30
+43% +$598 ﹤0.01% 2060
2025
Q3 		$1.43K Sell
70
-14
-17% -$282 ﹤0.01% 2067
2025
Q2 		$1.69K Hold
84
– – ﹤0.01% 2002
2025
Q1 		$1.65K Buy
+84
New +$1.81K ﹤0.01% 1978

Other funds holding ELVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

MassMutual Private Wealth & Trust's ELVN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Enliven Therapeutics (ELVN) position steady in Q2 2026 at 208 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

MassMutual Private Wealth & Trust first reported a position in ELVN in Q1 2025 and has held it in 6 quarters since. 212 funds tracked by Wall St. Rank hold ELVN as of Q2 2026.

  • MassMutual Private Wealth & Trust held 208 shares of Enliven Therapeutics worth $10.6K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Enliven Therapeutics share count unchanged in Q2 2026.
  • Enliven Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1388 holding.
  • MassMutual Private Wealth & Trust first reported a position in Enliven Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 212 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.